AGURACINGENE CADOPARVOVEC
UNII UF5FV8MLZ2

Substance Identification & Data

This profile provides standardized clinical and technical data for Aguracingene Cadoparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UF5FV8MLZ2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2417550-70-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

UF5FV8MLZ2

CAS Registry Number

2417550-70-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AGURACINGENE CADOPARVOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C184851

National Cancer Institute reference terminology for clinical and research data.

INN ID

12077

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-79

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Aguracingene Cadoparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AGURACINGENE CADOPARVOVEC

Common Names & Synonyms

AGURACINGENE CADOPARVOVEC [INN]

AGURACINGENE CADOPARVOVEC [USAN]

DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS 8 VECTOR AAV-CNGA PROMOTER HG1.7P-REGULATED HUMAN RETINAL CONE CYCLIC NUCLEOTIDE-GATED CATION CHANNEL SUBUNIT .ALPHA.3 CODON-OPTIMIZED GENE CNGA3 PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS)

Technical Codes

AAV-CNGA3

External Clinical & Regulatory Resources

Previous UNIIUF5CSU3HA6

Next UNIIUF5TYU93HS